These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6696484)

  • 1. Hyperpigmentation with daunorubicin therapy.
    Kelly TM; Fishman LM; Lessner HE
    Arch Dermatol; 1984 Feb; 120(2):262-3. PubMed ID: 6696484
    [No Abstract]   [Full Text] [Related]  

  • 2. Nail pigmentation with daunorubicin therapy.
    deMarinis M; Hendricks A; Stoltzner G
    Ann Intern Med; 1978 Oct; 89(4):516-7. PubMed ID: 697234
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous pigmentation after daunorubicin chemotherapy.
    Anderson LL; Thomas DE; Berger TG; Vukelja SJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):255-6. PubMed ID: 1552062
    [No Abstract]   [Full Text] [Related]  

  • 4. Minocycline-induced hyperpigmentation.
    Hung PH; Caldwell JB; James WD
    J Fam Pract; 1995 Aug; 41(2):183-5. PubMed ID: 7636458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized hyperpigmentation with daunorubicin chemotherapy.
    Kroumpouzos G; Travers R; Allan A
    J Am Acad Dermatol; 2002 Feb; 46(2 Suppl Case Reports):S1-3. PubMed ID: 11807454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin induced hyperpigmentation.
    Kumar L; Kochupillai V
    N Z Med J; 1990 Apr; 103(887):165. PubMed ID: 2342686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nail hyperpigmentation as a secondary effect of doxorubicin].
    Sanz Ortiz J; Méndez Batán MA; Fariñas Alvarez C; Gutiérrez del Río C
    Med Clin (Barc); 1982 Jun; 79(1):49-50. PubMed ID: 7121110
    [No Abstract]   [Full Text] [Related]  

  • 8. Serpentine supravenous 5-fluorouracil (NSC-19893) hyperpigmentation.
    Hrushesky WJ
    Cancer Treat Rep; 1976 May; 60(5):639. PubMed ID: 991154
    [No Abstract]   [Full Text] [Related]  

  • 9. Photo quiz. Blue-gray centrofacial hyperpigmentation.
    Rubegni P; de Aloe G; Maritati E; Mondillo S
    Am Fam Physician; 2001 Apr; 63(7):1409-10. PubMed ID: 11310653
    [No Abstract]   [Full Text] [Related]  

  • 10. The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population.
    Roberts G; Capell HA
    J Rheumatol; 2006 Jul; 33(7):1254-7. PubMed ID: 16758512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperpigmentation and zidovudine].
    Valencia ME; López Duplá JM; Lavilla P; Gil Aguado A
    Med Clin (Barc); 1989 Mar; 92(9):357-8. PubMed ID: 2716434
    [No Abstract]   [Full Text] [Related]  

  • 12. Imatinib-associated hyperpigmentation, a side effect that should be recognized.
    Mcpherson T; Sherman V; Turner R
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):82-3. PubMed ID: 18384557
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cutaneous hyperpigmentation and vidarabine].
    Cirera L; Palou J; Estapé J
    Med Clin (Barc); 1983 Nov; 81(15):693. PubMed ID: 6656419
    [No Abstract]   [Full Text] [Related]  

  • 14. Imipramine-induced hyperpigmentation: a case report and review of the literature.
    D'Agostino ML; Risser J; Robinson-Bostom L
    J Cutan Pathol; 2009 Jul; 36(7):799-803. PubMed ID: 19519613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corneal pigmentation due to amiodarone therapy (author's transl)].
    Zhang YZ
    Zhonghua Yan Ke Za Zhi; 1981 Nov; 17(6):346-8. PubMed ID: 6806030
    [No Abstract]   [Full Text] [Related]  

  • 16. Doxorubicin-associated hyperpigmentation.
    Curran CF
    N Z Med J; 1990 Oct; 103(900):517. PubMed ID: 2234654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hyperpigmentation due to ovulation inhibitors].
    Braun-Falco EO
    Dtsch Med Wochenschr; 1972 Jan; 97(2):57-8. PubMed ID: 5008206
    [No Abstract]   [Full Text] [Related]  

  • 18. The histopathology of subcutaneous minocycline pigmentation.
    Bowen AR; McCalmont TH
    J Am Acad Dermatol; 2007 Nov; 57(5):836-9. PubMed ID: 17939935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing our understanding of pigmentary disorders.
    Grimes P; Nordlund JJ; Pandya AG; Taylor S; Rendon M; Ortonne JP
    J Am Acad Dermatol; 2006 May; 54(5 Suppl 2):S255-61. PubMed ID: 16631966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Serpentine supravenous fluorouracil hyperpigmentation.
    Hrushesky WJ
    JAMA; 1976 Jul; 236(2):138. PubMed ID: 947001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.